Medicared For All Logo

Patricia Mooney in Encinitas, California

Home California Encinitas

Patricia Mooney has Nurse Practitioner as her primary medical specialty. Their primary office is: 326 Santa Fe Dr in Encinitas, California. There is an additional office location, for a total of two, for Patricia Mooney that can be viewed further down.

They're a part of the: California Cancer Associates For Research And Excellence Inc medical group which has around 45 members. You can call their office at 760-452-3340 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2020 (around 4 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Patricia Jean Mooney Office Phone and Directions

Patricia Mooney
California Cancer Associates For Research And Excellence Inc
326 Santa Fe Dr
Encinitas, California 92024
760-452-3340


Patient Ratings
Please rate your experience with Patricia Mooney below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 760-452-3340


Enter a starting address:


Healthcare Info for Patricia Mooney

Medical School: Sorry, her university is not listed
Graduation Year: 2020
The Primary Medical Specialty for Patricia Mooney is listed as: Nurse Practitioner
Approximate Years of Experience: 4
PAC (PECOS ID)#: 5294142964
NPI #: 1700470200
NPI Created On: 02/24/2021
NPI Last Updated Listed as: 05/10/2022
Primary Taxonomy Code: 363L00000X
License Number:
95015705
Listed Gender: Female

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788586689

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788586691

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $95

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788586693

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788586695

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09


Payments Total: $6

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788586699

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788586697

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $6

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788586701

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05


Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788586703

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05


Payments Total: $86

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788586705

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788586707

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Additional Office Locations

1. California Cancer Associates For Research And Excellence Inc
838 Nordahl Rd
San Marcos, CA 92069
Suite 300
Group Members: 45

Phone: 760-452-3340

Enter a starting address:


Nurse Practitioner Professionals in Encinitas

320 Santa Fe Dr
Encinitas, CA
Genesis Healthcare Partners

1130 2nd St
Encinitas, CA
North County Health Project, Inc.

781 Garden View Ct
Encinitas, CA
Genesis Healthcare Partners

320 Santa Fe Dr
Encinitas, CA
Genesis Healthcare Partners

320 Santa Fe Dr
Encinitas, CA
San Diego Cardiovascular Associates Medical Group Inc

310 Santa Fe Dr
Encinitas, CA
Scripps Health

Providers in California Cancer Associates For Research And Excellence Inc

1.Casandra Anderson Md

7130 N Millbrook Ave
Fresno Ca 93720-3347
California Cancer Associates For Research And Excellence Inc
Surgical Oncology

2.Amardeep Aulakh

7130 N Millbrook Ave
Fresno Ca 93720-3347
California Cancer Associates For Research And Excellence Inc
Internal Medicine

3.Pushpendu Banerjee Md

9850 Genesee Ave
La Jolla Ca 92037-1229
California Cancer Associates For Research And Excellence Inc
Medical Oncology

4.Pushpendu Banerjee Md

25405 Hancock Ave
Murrieta Ca 92562-5978
California Cancer Associates For Research And Excellence Inc
Medical Oncology

5.Pushpendu Banerjee Md

7130 N Millbrook Ave
Fresno Ca 93720-3347
California Cancer Associates For Research And Excellence Inc
Medical Oncology

6.Pushpendu Banerjee Md

838 Nordahl Rd
San Marcos Ca 92069-3599
California Cancer Associates For Research And Excellence Inc
Medical Oncology

View all 45 members of California Cancer Associates For Research And Excellence Inc medical group